To investigate the mechanism of increased radio- and chemo-sensitivity upon NOTCH inhibition, we evaluated the expression of the glioma stem cell marker CD133 using flow cytometry 4 days post-treatment in U87 and E2 cells grown under adherent stem cell conditions (Figure 6A–6B). Here, PROM1 is linked to glioma.